tiprankstipranks
Trending News
More News >
Vectus Biosystems Limited (AU:VBS)
:VBS
Australian Market

Vectus Biosystems Limited (VBS) Stock Statistics & Valuation Metrics

Compare
2 Followers

Total Valuation

Vectus Biosystems Limited has a market cap or net worth of AU$2.02M. The enterprise value is AU$18.22M.
Market CapAU$2.02M
Enterprise ValueAU$18.22M

Share Statistics

Vectus Biosystems Limited has 53,278,313 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,278,313
Owned by Insiders
Owned by Institutions

Financial Efficiency

Vectus Biosystems Limited’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -102.76%.
Return on Equity (ROE)-1.57
Return on Assets (ROA)-1.15
Return on Invested Capital (ROIC)-102.76%
Return on Capital Employed (ROCE)-1.52
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.56
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Vectus Biosystems Limited is -1.73. Vectus Biosystems Limited’s PEG ratio is 0.15.
PE Ratio-1.73
PS Ratio0.00
PB Ratio5.99
Price to Fair Value2.72
Price to FCF-8.90
Price to Operating Cash Flow-8.97
PEG Ratio0.15

Income Statement

In the last 12 months, Vectus Biosystems Limited had revenue of 1.14M and earned -2.34M in profits. Earnings per share was -0.04.
Revenue1.14M
Gross Profit1.14M
Operating Income-2.27M
Pretax Income-3.40M
Net Income-2.34M
EBITDA-2.27M
Earnings Per Share (EPS)-0.04

Cash Flow

In the last 12 months, operating cash flow was -1.44M and capital expenditures 27.01K, giving a free cash flow of -1.41M billion.
Operating Cash Flow-1.44M
Free Cash Flow-1.41M
Free Cash Flow per Share-0.03

Dividends & Yields

Vectus Biosystems Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.72
52-Week Price Change-50.00%
50-Day Moving Average0.06
200-Day Moving Average0.07
Relative Strength Index (RSI)22.55
Average Volume (3m)40.82K

Important Dates

Vectus Biosystems Limited upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateFeb 21, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date

Financial Position

Vectus Biosystems Limited as a current ratio of 3.45, with Debt / Equity ratio of 1.99%
Current Ratio3.45
Quick Ratio3.45
Debt to Market Cap0.00
Net Debt to EBITDA0.34
Interest Coverage Ratio-260.87

Taxes

In the past 12 months, Vectus Biosystems Limited has paid -1.06M in taxes.
Income Tax-1.06M
Effective Tax Rate0.31

Enterprise Valuation

Vectus Biosystems Limited EV to EBITDA ratio is -1.44, with an EV/FCF ratio of -1.55.
EV to Sales2.87
EV to EBITDA-1.44
EV to Free Cash Flow-1.55
EV to Operating Cash Flow-1.61

Balance Sheet

Vectus Biosystems Limited has AU$809.89K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$809.89K billion.
Cash & Marketable SecuritiesAU$809.89K
Total DebtAU$0.00
Net Cash-AU$809.89K
Net Cash Per Share-AU$0.02
Tangible Book Value Per ShareAU$0.03

Margins

Gross margin is 96.51%, with operating margin of -199.41%, and net profit margin of -205.34%.
Gross Margin96.51%
Operating Margin-199.41%
Pretax Margin-298.51%
Net Profit Margin-205.34%
EBITDA Margin-199.41%
EBIT Margin-204.57%

Analyst Forecast

The average price target for Vectus Biosystems Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast9.19%

Scores

Smart Score2
AI Score38
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis